PGAP3 Positive Control for STJ502444 peptide (STJ504694)

SKU:
STJ504694-5

Shipping:
Free Shipping
Current Stock:
Applications: WB
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: PGAP3 Positive Control for STJ502444 is synthetically produced from the sequence and is suitable for use in western blot applications.
Formulation: Provided as 100 uL ready-to-use, in SDS-PAGE sample buffer (Laemelli's buffer) containing Tris, pH 6.8, 1 % SDS, Glycerol and Bromophenolblue blue as tracking dye. The sample is reduced by adding 2% beta mercaptoethanol. The protein concentration is
Dilution Range: WB: 1:500-1:1, 000
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: PGAP3
Gene ID: 93210
Uniprot ID: PGAP3_HUMAN
Specificity: This is positive control is recommended for use in combination with PGAP3 antibody STJ502444.
Tissue Specificity Ubiquitously expressed, with highest levels in thyroid and placenta.
Function Involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins. Required for phospholipase A2 activity that removes an acyl-chain at the sn-2 position of GPI-anchors during the remodeling of GPI.
Peptide Name Post-Gpi Attachment To Proteins Factor 3
Cos16 Homolog
Hcos16
Gene Coamplified With Erbb2 Protein
Per1-Like Domain-Containing Protein 1
Cellular Localisation Golgi Apparatus Membrane
Multi-Pass Membrane Protein
Endoplasmic Reticulum Membrane
Mainly Localizes To Golgi Apparatus
Alternative Peptide Names Post-Gpi Attachment To Proteins Factor 3 protein
Cos16 Homolog protein
Hcos16 protein
Gene Coamplified With Erbb2 Protein protein
Per1-Like Domain-Containing Protein 1 protein
PGAP3 protein
CAB2 protein
PERLD1 protein
UNQ546 protein
PRO1100 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance